Woodford Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,875,358
Closed -$344M 7
2017
Q3
$344M Sell
3,875,358
-7,979,400
-67% -$607M 15.81% 4
2017
Q2
$860M Buy
11,854,758
+937,500
+9% +$63M 31.57% 1
2017
Q1
$711M Sell
10,917,258
-315,500
-3% -$19.8M 29.45% 1
2016
Q4
$703M Buy
11,232,758
+202,958
+2% +$12.4M 33.86% 1
2016
Q3
$696M Sell
11,029,800
-627,000
-5% -$40.6M 28.12% 1
2016
Q2
$722M Buy
11,656,800
+593,500
+5% +$36.2M 33.91% 1
2016
Q1
$632M Buy
11,063,300
+2,269,300
+26% +$126M 28.87% 2
2015
Q4
$521M Buy
8,794,000
+3,516,200
+67% +$203M 22.35% 2
2015
Q3
$287M Buy
+5,277,800
New +$344M 16.58% 3

Other funds holding ABBV

Woodford Investment Management's ABBV Position: Q4 2017 in Review

Woodford Investment Management sold out of AbbVie (ABBV) in Q4 2017, closing a stake of 3,875,358 shares — an estimated $344M sold.

Woodford Investment Management first reported a position in ABBV in Q3 2015 and held it in 9 quarters. The position peaked at $860M in Q2 2017. 2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • Woodford Investment Management reported no remaining AbbVie position as of Q4 2017 after selling out during the quarter.
  • Woodford Investment Management sold 3,875,358 AbbVie shares in Q4 2017, an estimated $344M.
  • Woodford Investment Management first reported a position in AbbVie in Q3 2015 and held it in 9 quarters.
  • Woodford Investment Management's AbbVie position peaked at $860M in Q2 2017.
  • 2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Woodford Investment Management's 13F filing for Q4 2017, filed 13 Feb 2018.